All In Biotech

Drug Trial Radar · NCT00438113

Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF

Last checked: Nov 20, 2026Latest source record: Jun 20, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 184 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

184

Actual

Start

Dec 2009

Primary completion

Sep 2016

Study completion Sep 2016

Sponsor

Lead sponsor
Nova Scotia Health AuthorityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Nova Scotia Health Research Foundation
First posted
Feb 21, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Atrial fibrillation (AF) is a very common arrhythmia causing many symptoms resulting in numerous hospitalizations. Catheter ablation is a technique that has evolved significantly to improve symptomatic recurrences, but does not offer a 100% cure rate. We hypothesize that the use of aggressive BP lowering will reduce the rate of recurrent AF after catheter ablation for AF. We plan a randomized clinical trial of aggressive BP lowering versus standard BP control to investigate this.

Conditions

  • Atrial Fibrillation

Interventions

  • Aggressive Blood Pressure controlDrug

    Aggressive Blood Pressure therapy, alone or combination therapy, to reach a target BP equal to or less than 120/80 mmHg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to symptomatic AF/atrial tachycardia (AT)/atrial flutter (AFl) lasting > 30 seconds more than 3 months post ablation.Time frame: at least 3 months post catheter ablation

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • QE II Health Sciences Centre

    Halifax, Nova Scotia, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.